We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Novel Deep Learning Drug Discovery Platform gets £1 Million Innovation Boost

Product News

Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery.

READ MORE

Public Launch of Porvair Lab Division

Product News

Porvair has chosen Lab Innovations 2018 to bring together, for the first time on a single exhibition stand (G16), all the latest products and application solutions from its fast-growing Laboratory Division.

READ MORE


Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE